Moderator: Viktor Gruenwald, MD PhD (he/him/his) – Essen University Hospital, West German Cancer Center, Clinic for Medical Oncology & Clinical for Urology, Essen, Germany
Industry Session - MSD - Recent advances in the management of Renal cell Carcinoma
Location: Lammermuir 1&2
Speaker: Viktor Gruenwald, MD PhD (he/him/his) – Essen University Hospital, West German Cancer Center, Clinic for Medical Oncology & Clinical for Urology, Essen, Germany
Oral Abstract: Patients’ experiences on the course of treatment after partial nephrectomy or percutaneous cryoablation of small renal cell carcinoma - a cross-sectional multicenter study
Location: Lenox 3
Lead Author: Theresa Junker, PhD – Research and Innovation Unit of Radiology
Patient-reported Outcomes
Poster Session
Friday, Apr 21st
12:45 – 14:15 GMT
POSTERS AND LUNCH
Location: Lenox 1
Poster SessionNetworking
Saturday, Apr 22nd
12:10 – 13:40 GMT
POSTERS AND LUNCH
Location: Lenox 1
Poster SessionNetworking
Quality of Care and Quality Improvement
Friday, Apr 21st
14:27 – 14:37 GMT
Oral Abstract: Health Related Quality of Life (HR-QOL) Measures in Renal Cell Carcinoma: Patient-reported relevance of items of the FKSI-19, EORTC QLQ-C30 and EQ-5D.
Oral Abstract: Cross-trial propensity score weighted analysis of nivolumab plus ipilimumab versus nivolumab monotherapy for patients with untreated advanced renal cell carcinoma
Oral Abstract: Eosinophilic solid and cystic renal cell carcinoma : a rare new entity associated with TSC1/TSC2 genetic alteration and rare metastatic potential.
Oral Abstract: Baseline circulating soluble factors as predictors of benefit from nivolumab in metastatic renal cell carcinoma (mRCC): additional multivariate analyses of the pooled translational NIVOREN GETUG-AFU26 population
